Advances in the study of histaminergic systems and sleep-wake regulation

Yaoxue Xuebao

Volumn 46, Issue 3, 2011, Pages 247-252

  Liu, Tian Ya ^a   Hong, Zong Yuan ^a   Qu, Wei Min ^b   Huang, Zhi Li ^b  

^a WANNAN MEDICAL COLLEGE   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Adenosine; Histaminergic system; Orexin; Prostaglandin D 2; Prostaglandin E 2; Sleep wake regulation

Indexed keywords

4 AMINOBUTYRIC ACID; HISTAMINE; HYPNOTIC SEDATIVE AGENT; PROSTAGLANDIN D2;

4 AMINOBUTYRIC ACID RELEASE; CENTRAL NERVOUS SYSTEM; HISTAMINE RELEASE; HISTAMINERGIC SYSTEM; REVIEW; SLEEP WAKING CYCLE;

ADENOSINE; ANIMALS; DINOPROSTONE; GAMMA-AMINOBUTYRIC ACID; HISTAMINE; HYPOTHALAMIC AREA, LATERAL; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NEURONS; NEUROPEPTIDES; PROSTAGLANDIN D2; SLEEP; WAKEFULNESS;

EID: 79953249070     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Brown RE, Stevens DR, Haas HL. The physiology of brain histamine [J]. Prog Neurobiol, 2001, 63: 637-672.
2. Haas HL, Panula P. The role of histamine and the tuberomamillary nucleus in the nervous system [J]. Nat Rev Neurosci, 2003, 4: 121-130. (Pubitemid 37271382)
3. Simons FE. H1-receptor antagonists. Comparative tolerability and safety [J]. Drug Saf, 1994, 10: 350-380.
4. Itowi N, Yamatodani A, Kiyono S, et al. Effect of histamine depletion on the circadian amplitude of the sleep-wakefulness cycle [J]. Physiol Behav, 1991, 49: 643-646.
5. Tuomisto L, Lozeva V, Valjakka A, et al. Modifying effects of histamine on circadian rhythms and neuronal excitability [J]. Behav Brain Res, 2001, 124: 129-135. (Pubitemid 32964630)
6. Haas HL, Sergeeva OA, Selbach O. Histamine in the nervous system [J]. Physiol Rev, 2008, 88: 1183-1241.
7. Bakker RA, Casarosa P, Timmerman H, et al. Constitutively active Gq/11-coupled receptors enable signaling by co-expressed G(i/o)-coupled receptors [J]. J Biol Chem, 2004, 279: 5152-5161.
8. Arrang JM, Garbarg M, Schwartz JC. Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor [J]. Nature, 1983, 302: 832-837.
9. Chu M, Huang ZL, Qu WM, et al. Extracellular histamine level in the frontal cortex is positively correlated with the amount of wakefulness in rats [J]. Neurosci Res, 2004, 49: 417-420. (Pubitemid 38953859)
10. Mochizuki T, Yamatodani A, Okakura K, et al. Circadian rhythm of histamine release from the hypothalamus of freely moving rats [J]. Physiol Behav, 1992, 51: 391-394.
11. Strecker RE, Nalwalk J, Dauphin LJ, et al. Extracellular histamine levels in the feline preoptic/anterior hypothalamic area during natural sleep-wakefulness and prolonged wakefulness: an in vivo microdialysis study [J]. Neuroscience, 2002, 113: 663-670. (Pubitemid 34874690)
12. Prell GD, Khandelwal JK, Bums RS, et al. Diurnal fluctuation in levels of histamine metabolites in cerebrospinal fluid of rhesus monkey [J]. Agents Actions, 1989, 26: 279-286. (Pubitemid 19078121)
13. Kiviranta T, Tuomisto L, Airaksinen EM. Diurnal and age-related changes in cerebrospinal fluid tele-methylhistamine levels during infancy and childhood [J]. Pharmacol Biochem Behav, 1994, 49: 997-1000. (Pubitemid 24376041)
14. Lin JS, Sakai K, Jouvet M. Evidence for histaminergic arousal mechanisms in the hypothalamus of cat [J]. Neuropharmacology, 1988, 27: 111-122. (Pubitemid 18052351)
15. Estelle F, Simons R. H1-receptor antagonists: safety issues [J]. Ann Allergy Asthma Immunol, 1999, 83: 481-488.
16. Huang ZL, Qu WM, Li WD, et al. Arousal effect of orexin A depends on activation of the histaminergic system [J]. Proc Natl Acad Sci U S A, 2001, 98: 9965-9970.
17. Inoue I, Yanai K, Kitamura D, et al. Impaired locomotor activity and exploratory behavior in mice lacking histamine H1 receptors [J]. Proc Natl Acad Sci USA, 1996, 93: 13316-13320.
18. Lin JS. Brain structures and mechanisms involved in the control of cortical activation and wakefulness, with emphasis on the posterior hypothalamus and histaminergic neurons [J]. Sleep Med Rev, 2000, 4: 471-503.
19. Narumiya S, Sugimoto Y, Ushikubi F. Prostanoid receptors: structures, properties, and functions [J]. Physiol Rev, 1999, 79: 1193-1226. (Pubitemid 29473315)
20. Gerozissis K, De Saint Hilaire Z, Orosco M, et al. Changes in hypothalamic prostaglandin E2 may predict the occurrence of sleep or wakefulness as assessed by parallel EEG and microdialysis in the rat [J]. Brain Res, 1995, 689: 239-244.
21. Huang ZL, Sato Y, Mochizuki T, et al. Prostaglandin E2 activates the histaminergic system via the EP4 receptor to induce wakefulness in rats [J]. J Neurosci, 2003, 23: 5975-5983.
22. de Lecea L, Kilduff TS, Peyron C, et al. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity [J]. Proc Natl Acad Sci USA, 1998, 95: 322-327. (Pubitemid 28103952)
23. Sakurai T, Amemiya A, Ishii M, et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior [J]. Cell, 1998, 92: 573-585. (Pubitemid 28101119)
24. Marcus JN, Aschkenasi CJ, Lee CE, et al. Differential expression of orexin receptors 1 and 2 in the rat brain [J]. J Comp Neurol, 2001, 435: 6-25. (Pubitemid 32448719)
25. Kiyashchenko LI, Mileykovskiy BY, Maidment N, et al. Release of hypocretin (orexin) during waking and sleep states [J]. J Neurosci, 2002, 22: 5282-5286. (Pubitemid 35386448)
26. Chemelli RM, Willie JT, Sinton CM, et al. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation [J]. Cell, 1999, 98: 437-451. (Pubitemid 29402482)
27. Lin L, Faraco J, Li R, et al. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene [J]. Cell, 1999, 98: 365-376. (Pubitemid 29380571)
28. Nishino S, Ripley B, Overeem S, et al. Low cerebrospinal fluid hypocretin (Orexin) and altered energy homeostasis in human narcolepsy [J]. Ann Neurol, 2001, 50: 381-388. (Pubitemid 32848741)
29. Mignot E, Lammers GJ, Ripley B, et al. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias [J]. Arch Neurol, 2002, 59: 1553-1562.
30. Huang ZL, Qu WM, Li WD, et al. Arousal effect of orexin A depends on activation of the histaminergic system [J]. Proc Natl Acad Sci U S A, 2001, 98: 9965-9970.
31. Nishino S, Fujiki N, Ripley B, et al. Decreased brain histamine content in hypocretin/orexin receptor-2 mutated narcoleptic dogs [J]. Neurosci Lett, 2001, 313: 125-128. (Pubitemid 33022586)
32. Kanbayashi T, Kodama T, Kondo H, et al. CSF histamine contents in narcolepsy, idiopathic hypersomnia and obstructive sleep apnea syndrome [J]. Sleep, 2009, 32: 181-187.
33. Eriksson KS, Sergeeva O, Brown RE, et al. Orexin/hypocretin excites the histaminergic neurons of the tuberomammillary nucleus [J]. J Neurosci, 2001, 21: 9273-9279. (Pubitemid 33096871)
34. Szymusiak R, Alam N, Steininger TL, et al. Sleep-waking discharge patterns of ventrolateral preoptic/anterior hypothalamic neurons in rats [J]. Brain Res, 1998, 803: 178-188. (Pubitemid 28392144)
35. Scammell TE, Gerashchenko DY, Mochizuki T, et al. An adenosine A2a agonist increases sleep and induces Fos in ventrolateral preoptic neurons [J]. Neuroscience, 2001, 107: 653-663. (Pubitemid 33097501)
36. Hayaishi O, Matsumura H. Prostaglandins and sleep [J]. Adv Neuroimmunol, 1995, 5: 211-216.
37. Fu CF, Hong ZY. Effects of prostaglandin D2 on sleep regulation [J]. Chin J Clin Pharmacol Ther 2005, 10: 1321-1325.
38. Mizoguchi A, Eguchi N, Kimura K, et al. Dominant localization of prostaglandin D receptors on arachnoid trabecular cells in mouse basal forebrain and their involvement in the regulation of non-rapid eye movement sleep [J]. Proc Natl Acad Sci U S A, 2001, 98: 11674-11679. (Pubitemid 32928787)
39. Eguchi N, Qu WM, Huang ZL, et al. Molecular mechanism of prostaglandin D2-mediated sleep homeostasis studied by DP receptor-deficient mice [J]. Sleep Biol Rhythms, 2004, 90: 17-18.
40. Matsumura H, Nakajima T, Osaka T, et al. Prostaglandin D2-sensitive, sleep-promoting zone defined in the ventral surface of the rostral basal forebrain [J]. Proc Natl Acad Sci USA, 1994, 91: 11998-12002. (Pubitemid 24368591)
41. Satoh S, Matsumura H, Suzuki F, et al. Promotion of sleep mediated by the A2a-adenosine receptor and possible involvement of this receptor in the sleep induced by prostaglandin D2 in rats [J]. Proc Natl Acad Sci USA, 1996, 93: 5980-5984.
42. Huang ZL, Yoshihiro U, Osamu H. The role of adenosine in the regulation of sleep [J]. Curr Top Med Chem, 2011, in press.
43. Ferre S, Diamond I, Goldberg SR, et al. Adenosine A2A receptors in ventral striatum, hypothalamus and nociceptive circuitry implications for drug addiction, sleep and pain [J]. Prog Neurobiol, 2007, 83: 332-347. (Pubitemid 350110608)
44. Jacobson KA, Gao ZG. Adenosine receptors as therapeutic targets [J]. Nat Rev Drug Discov, 2006, 5: 247-264.
45. Hong ZY, Huang ZL, Qu WM, et al. An adenosine A2A receptor agonist induces sleep by increasing GABA release in the tuberomammillary nucleus to inhibit histaminergic systems in rats [J]. J Neurochem, 2005, 92: 1542-1549.
46. Fredholm BB, AP IJ, Jacobson KA, et al. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors [J]. Pharmacol Rev, 2001, 53: 527-552. (Pubitemid 33136237)
47. Huang ZL, Qu WM, Eguchi N, et al. Adenosine A2A, but not Al, receptors mediate the arousal effect of caffeine [J]. Nat Neurosci, 2005, 8: 858-859.
48. Oishi Y, Huang ZL, Fredholm BB, et al. Adenosine in the tuberomammillary nucleus inhibits the histaminergic system via A1 receptors and promotes non-rapid eye movement sleep [J]. Proc Natl Acad Sci USA, 2008, 105: 19992-19997.
49. Huang ZL, Urade Y, Hayaishi O. Prostaglandins and adenosine in the regulation of sleep and wakefulness [J]. Curr Opin Pharmacol, 2007, 7: 33-38. (Pubitemid 46238038)
50. Huang ZL, Urade Y, Hayaishi O. Key roles of the histaminergic system in sleep-wake regulation [J]. Sleep Biol Rhythms, 2011, 9 (Suppl 1), in press.